Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.437NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.437NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.371ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.371ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.371SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.371SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.371EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.371NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.371NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.4.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.4.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.4.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.6.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FY.6.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FY.6.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FY.6.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FY.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HU.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
HU.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HU.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
HU.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
HU.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HU.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.4.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
EG.1.4.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
EG.1.4.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EG.1.4.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
EG.1.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KJ.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
KJ.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-16402.8South Korea
KJ.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
KJ.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
KJ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used